Header cover image

Indonesian (IDX) Pharma Industry Analysis

UpdatedMar 01, 2026
DataAggregated Company Financials
Companies8
  • 7D1.2%
  • 3M9.7%
  • 1Y43.0%
  • YTD10.4%

Over the last 7 days, the Pharma industry has risen 1.2%, driven by gains from Kalbe Farma of 4.3%. During this same period, the Pyridam Farma underperformed, falling 7.2%. This means that the industry has gained 43% over the past year. Looking forward, earnings are forecast to grow by 9.8% annually.

Industry Valuation and Performance

Has the Indonesian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 01 Mar 2026Rp108.3tRp74.5tRp4.6t10.7x23.5x1.5x
Tue, 27 Jan 2026Rp110.8tRp74.5tRp4.6t10.8x24x1.5x
Thu, 25 Dec 2025Rp96.7tRp74.3tRp4.6t10.7x21.1x1.3x
Sat, 22 Nov 2025Rp101.4tRp74.3tRp4.6t10.7x22.2x1.4x
Mon, 20 Oct 2025Rp93.4tRp73.2tRp4.2t11.3x22.5x1.3x
Wed, 17 Sep 2025Rp85.6tRp73.2tRp4.2t11.4x20.6x1.2x
Fri, 15 Aug 2025Rp96.7tRp73.6tRp4.0t11.8x24x1.3x
Sun, 13 Jul 2025Rp101.5tRp73.2tRp4.1t11x24.7x1.4x
Tue, 10 Jun 2025Rp102.7tRp72.8tRp3.3t11.4x31.2x1.4x
Thu, 08 May 2025Rp95.1tRp87.0tRp3.9t10.8x24.7x1.1x
Sat, 05 Apr 2025Rp79.0tRp71.7tRp3.5t10.2x22.9x1.1x
Mon, 03 Mar 2025Rp76.6tRp70.6tRp3.1t12.1x24.4x1.1x
Wed, 29 Jan 2025Rp85.3tRp70.6tRp3.1t12.7x27.1x1.2x
Fri, 27 Dec 2024Rp93.5tRp70.6tRp3.1t13x29.7x1.3x
Sun, 24 Nov 2024Rp98.3tRp70.6tRp3.1t12.4x31.3x1.4x
Tue, 22 Oct 2024Rp108.8tRp68.9tRp3.2t12.5x33.5x1.6x
Thu, 19 Sep 2024Rp111.2tRp68.8tRp3.3t12.6x33.6x1.6x
Sat, 17 Aug 2024Rp106.6tRp68.9tRp3.4t12.8x31.1x1.5x
Mon, 15 Jul 2024Rp98.6tRp67.5tRp3.0t11.6x33.2x1.5x
Wed, 12 Jun 2024Rp100.1tRp67.4tRp3.1t15.9x32.4x1.5x
Fri, 10 May 2024Rp88.9tRp67.7tRp4.4t12.8x20.2x1.3x
Sun, 07 Apr 2024Rp92.9tRp66.7tRp4.4t11.2x21.2x1.4x
Tue, 05 Mar 2024Rp93.4tRp65.9tRp4.7t18.7x19.7x1.4x
Thu, 01 Feb 2024Rp94.9tRp65.9tRp4.7t17.1x20x1.4x
Sat, 30 Dec 2023Rp102.0tRp65.9tRp4.7t18.7x21.5x1.5x
Mon, 27 Nov 2023Rp97.8tRp65.8tRp5.2t21.9x18.6x1.5x
Wed, 25 Oct 2023Rp105.6tRp65.6tRp5.4t21.4x19.6x1.6x
Fri, 22 Sep 2023Rp108.2tRp65.6tRp5.4t21.3x20x1.6x
Sun, 20 Aug 2023Rp109.5tRp65.6tRp5.4t21.4x20.3x1.7x
Tue, 18 Jul 2023Rp118.1tRp64.2tRp5.3t21.2x22.2x1.8x
Thu, 15 Jun 2023Rp118.9tRp64.2tRp5.3t21.3x22.4x1.9x
Sat, 13 May 2023Rp123.6tRp65.3tRp4.9t21.5x25.3x1.9x
Mon, 10 Apr 2023Rp120.2tRp65.3tRp4.9t18.2x24.7x1.8x
Wed, 08 Mar 2023Rp124.5tRp65.0tRp4.6t21.2x26.9x1.9x
Price to Earnings Ratio

26.9x


Total Market Cap: Rp124.5tTotal Earnings: Rp4.6tTotal Revenue: Rp65.0tTotal Market Cap vs Earnings and Revenue0%0%0%
Indonesian Pharma Industry Price to Earnings3Y Average 24.6x202420252026
Current Industry PE
  • Investors are relatively neutral on the Indonesian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 24.6x.
  • The industry is trading close to its 3-year average PS ratio of 1.5x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 4.7% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Indonesian Healthcare industry?

ID Market-0.88%
Healthcare-0.19%
Pharma1.16%
Pharma1.16%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
KLBF Kalbe FarmaRp1.10k4.3%
+Rp2.0t
1.9%PE14.3x
DVLA Darya-Varia LaboratoriaRp1.66k0.6%
+Rp11.2b
7.1%PE10.7x

Latest News